SEC 13F Intelligence

Oxford Asset Management LLP / ARRYEUR

Oxford Asset Management LLP’s Array Biopharma Inc Position

Does Oxford Asset Management LLP own Array Biopharma Inc (ARRYEUR)? Not currently — the last reported position was 470.3K shares worth $22M in Q2 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$22M
Q2 2019
Shares
470.3K
% of Portfolio
+0.49%
Quarters Held
1
position exited

Position History ARRYEUR

Reported value by quarter
Q2 ’19: $22MQ2 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2019470.3K$22M+0.49%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Oxford Asset Management LLP’s full portfolio or all institutional holders of ARRYEUR.